The FDA Dallas District, in cooperation with the Society of Clinical Research Associates(SoCRA), is announcing a workshop on FDA Clinical Trial statutory and regulatory requirements.

continue reading.....

Almost 60% of women use at least one herbal product during pregnancy, research launched at the British Pharmaceutical Conference (BPC) in Manchester has revealed.

continue reading.....

Basil can protect against the harmful effects of ageing, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

continue reading.....

CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches.

continue reading.....

Research presented at the British Pharmaceutical Conference (BPC) in Manchester reveals that coating an artificial lens with antibiotics could significantly reduce the risk of post-operative infection, and even blindness, for cataract patients.

continue reading.....

One in four patients with diabetes are not receiving the appropriate cardiovascular medications, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

continue reading.....

A third of patients have unnecessary tubes (cannulae) inserted when they are in hospital, needlessly exposing them to serious complications such as infection and blood clots, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown.

continue reading.....

The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

continue reading.....

New treatment using a light-activated drug could revolutionise the fight against hospital “superbug”, MRSA (otherwise known as Meticillin resistant staphylococcus aureus) it was revealed at the British Pharmaceutical Conference (BPC) in Manchester.

continue reading.....

More than a third of patients with long-term fatigue conditions like Myalgic Encephalomyelitis (ME) believe complementary and alternative medicines (CAMs) are more effective than traditional medicine in treating their illness, research launched at the British Pharmaceutical Conference (BPC) in Manchester reveals.

continue reading.....